Rotavac probably leads to lower severe cases of rotavirus diarrhoea compared with placebo (moderate certainty).
Rotavac probably leads to lower severe cases of all‐cause diarrhoea compared with placebo (moderate certainty).
It is very uncertain whether rotavac changes all‐cause death compared with placebo (very low certainty).
Rotavac showed no clear difference in all serious adverse events compared with placebo (moderate certainty).
It is very uncertain whether rotavac changes serious adverse events: intussusception compared with placebo (very low certainty).
The findings closest to your search, judged one by one by TypeSafe's Jev model.